Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
Part of paid clinical trials in Duarte, California.
- Sponsor
- City of Hope Medical Center
- Study ID
- NCT07664579
- Status
- Recruiting
Conditions
- Anatomic Stage IV Breast Cancer AJCC v8
- Glioblastoma
- Lung Carcinoma
- Malignant Solid Neoplasm
- Metastatic Breast Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Non-Interventional Study — OTHERNon-interventional study
Study Details
This study evaluates how useful and acceptable the components of the "Couples Coping Together Against Cancer", referred to as "The Program", are to the participants with cancer.
Key Dates
- Start date
- Jul 5, 2024
- Status verified
- Jun 2026
- Primary completion
- Nov 16, 2026
- Completion
- Nov 16, 2026
Study Design
- Enrollment
- 160 participants (estimated)
Arms
- Arm: ObservationalPatient and partners receive access to the Connecting Care App tool and undergo biopsychosocial screening and psychoeducation sessions over 30-45 minutes and complete surveys on study. Patients and partners may also receive counseling sessions over 30-45 minutes for up to 4 sessions on study.
Primary Outcome Measure
Accrual rate (AR) [ Time Frame: Up to 12 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| City of Hope Medical Center | Duarte | California | 91010 | William Dale (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Duarte, CA
By condition
By specialty
By research site
Related Studies
- Project: Every Child for Younger Patients With CancerRecruiting · Children's Oncology Group · Birmingham, Alabama
- Collection and Storage of Tissue and Blood Samples From Patients With CancerRecruiting · National Cancer Institute LAO · Birmingham, Alabama
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During SurgeryPHASE1/PHASE2 · Recruiting · Stanford University · Palo Alto, California